Home › Moberg Pharma Regains Rights to Emtrix in Certain EU Markets
 

Keywords :   


Moberg Pharma Regains Rights to Emtrix in Certain EU Markets

2015-11-10 13:33:33| Appliances - Topix.net

Moberg Pharma AB today announced that it has reached an agreement with its partner Meda to regain rights to EmtrixA in certain EU markets where the nail product has not yet been launched, including UK and Poland. Moberg Pharma and Meda have agreed to amend their existing license and distribution agreement so Moberg regains rights to the nail product in certain EU markets.

Tags: rights markets pharma regains

Category:Consumer Goods and Services

Latest from this category

All news
11.10UK-linked firms suspected of busting Russia sanctions
11.10How Chinas crackdown turned finance high-flyers into rats
11.10Why even at 20 you should care about pension changes
11.10Meet the team paid to break into top-secret bases
10.10EU delays introduction of border check system again
10.10How will the changes to workers' rights affect you?
10.10Labour's new deal for workers: A fight postponed?
10.10Fresh rise in mortgage rates predicted
Consumer Goods and Services »
11.10UK-linked firms suspected of busting Russia sanctions
11.10Atlantic Tropical Weather Outlook
11.10Eastern North Pacific Tropical Weather Outlook
11.10How Chinas crackdown turned finance high-flyers into rats
11.10Why even at 20 you should care about pension changes
11.10Meet the team paid to break into top-secret bases
10.102025 CoatingsTech Conference: Call for Papers Abstracts Due October 15, 2024
10.10Post-Tropical Cyclone Milton Graphics
More »